Skip to main content
. 2024 Feb 15;79(9):861–869. doi: 10.1136/thorax-2023-220377

Figure 1.

Figure 1

Indirect impact of 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and all-cause pneumonia in older adults aged ≥65 years in Ontario, 2005–2018. IPD, invasive pneumococcal disease; PCV, pneumococcal conjugate vaccine; PPV, pneumococcal polysaccharide vaccine; RRR, ratio of risk ratio.